Log In
BCIQ
Print this Print this
 

GC1101

  Manage Alerts
Collapse Summary General Information
Company Green Cross Corp.
DescriptionRecombinant Factor VIII
Molecular Target Factor VIII
Mechanism of ActionFactor VIII replacement
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentApproved
Standard IndicationHemophilia
Indication DetailsTreat hemophilia A
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today